Impact of antiplatelet pretreatment on stent thrombosis in patients undergoing PCI in real world practice: insight France PCI registry

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Gregoire Range

Hospital Louis Pasteur of Chartres, Chartres (France)

4 More presentations in this session

Presentation thumbnail

State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention

Professor D. Capodanno (Catania, IT)

Presentation thumbnail

Aspirin reloading before percutaneous coronary intervention on chronic aspirin therapy: reduced early ischemia without bleeding trade-off

Doctor W. Dai (Tianjin, CN)

Abstract Slides Video

Presentation thumbnail

A shorter duration of dual-antiplatelet therapy following percutaneous coronary intervention: a meta-analysis of randomized clinical trials

Doctor T. Fretz (Indianapolis, US)

Abstract Slides Video

Presentation thumbnail

12- vs. 1-month DAPT: comparative outcomes after aspirin cessation with HT supreme stent

Doctor T. Tsai (Galway, IE)

Abstract Slides Video

Access the full session

Session thumbnail

Adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention

Congress Presentation

Association of P2Y12 inhibitor pretreatment strategy with short and long term ischemic and bleeding outcomes in NSTE-ACS patients

Congress Presentation

Challenges in antiplatelet strategies in acute coronary syndromes: top tips for choosing wisely - discussion

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources